Some aspects of pathogenesis and prevention of sudden cardiac death in patients with chronic obstructive pulmonary disease


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Chronic obstructive pulmonary disease (COPD) is associated with an increased risk of sudden cardiac death (SCD), especially in patients with frequent exacerbations for 5 years after diagnosis. The article provides an overview of the problem of SCD in patients with COPD. Into the risk group of developing SCD we include patients with COPD with a previous pathology of the cardiovascular system (myocardial infarction, hypertension, arrhythmias), patients with severe COPD, who have phenotypes "frequent exacerbations" of respiratory disease. One of the main reasons that may underlie the development of sudden death, is the development of cardiac arrhythmias that most often recorded in patients with COPD undergoing extensive myocardial infarction. The pathogenesis of arrhythmias in patients with COPD is multifactorial. Detection of comorbidity in patients with COPD will allow to take into account their individual characteristics when choosing pharmacotherapy. COPD patients with a high risk of SCD is necessary to limit the frequent use of bronchodilators, in particular short-acting methylxanthines, drugs that can prolong the interval QT (for example, 14-membered macrolides).

Texto integral

Acesso é fechado

Sobre autores

Nina Karoli

V.I. Razumovsky Saratov State Medical University

MD, Professor of Department of Hospital Therapy

Andrey Rebrov

V.I. Razumovsky Saratov State Medical University

Email: andreyrebrov@yandex.ru
MD, professor, Head of Department of Hospital Therapy

Bibliografia

  1. Laratta C., van Eeden S. Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Cardiovascular Links. Biomed. Res. Int. 2014:528789. doi: 10.1155/2014/528789. Epub 2014 Mar 2.
  2. Кароли Н.А., Ребров А.П. Коморбидность у больных хронической обструктивной болезнью легких: место кардиоваскулярной патологии. Рациональная фармакотерапия в кардиологии. 2009;4:9-17. [Karolin N.A., Rebrov А.Р. Comorbidity in patients with chronic obstructive pulmonary disease: a place of cardiovascular pathology. Rational Pharmacotherapy in Cardiology. 2009;4:9-17 (in Russian)]
  3. Almagro P., Calbo E., Ochoa de Echagüen A., Barreiro B., Quintana S., Heredia J.L., Garau J. Mortality after hospitalization for COPD. Chest. 2002;121:1441-8.
  4. Engstrom G., Lind P., Hedblad B., Wollmer P., Stavenow L., Janzon L., Lindgärde F. Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation. 2002;106(20): 2555-60.
  5. Hansell A.L., Walk J.A., Soriano J.B. What do chronic obstructive pulmonary disease patients die from? A multiple case coding analysis. Eur. Respir. J. 2003;22:809-14.
  6. Pistelli R., Lange P., Miller D.L. Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity. Eur. Respir. J. 2003;21(Suppl 40):10s-14s.
  7. Sin D.D., Wu L., Man S.F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127:1952-9.
  8. Hawkins N.M., Huang Z., Pieper K.S., Solomon S.D., Kober L., Velazquez E.J., Swedberg K., Pfeffer M.A., McMurray J.J., Maggioni A.P. Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT). Eur. J. Heart Fail. 2009;11(3):292-8.
  9. Mapel D.W., Dedrick D., Davis K. Trends and cardiovascular co-morbidities of COPD patients in the Veterans Administration medical system, 1991-1999. COPD. 2005;2:35-41.
  10. Национальные рекомендации ОССН, РКО и РНМОТ по диагностике и лечению ХСН (четвертый пересмотр). Сердечная недостаточность. 2013;81:1-94. [National guidelines OSSN, RKO and RNMOT for diagnosis and treatment of chronic heart failure (fourth revision). Heart failure. 2013;81:1-94 (in Russian)]
  11. Buch P., Friberg J., Scharling H., Lange P., Prescott E. Reduced lung function and risk of atrial fibrillation in the Copenhagen City Heart Study. Eur. Resp. J. 2003; 21(6):1012-6.
  12. Ардашев А.В., Шляхто Е.В., Арутюнов Г.П., Беленков Ю.Н. Национальные рекомендации по определению риска и профилактике внезапной сердечной смерти. Клиническая практика. 2012;4(12):1-77. [Ardashev A.V., Shlyakhto E.V., Artyunov G.P., Belenkov Yu.N. National guidelines on the definition of risk and prevention of sudden cardiac death. Clinical practice. 2012;4(12):1-77 (in Russian)]
  13. Чучалин А.Г. Хроническая обструктивная болезнь легких и сопутствующая заболеваемость. Часть I. ХОБЛ и поражение сердечнососудистой системы. Русский медицинский журнал. 2008;2:58-64. [Chuchalin A.G. Chronic obstructive pulmonary disease and co-morbidity. Part I. COPD and the defeat of the cardiovascular system. Russian Medical Journal. 2008;2:58-64 (in Russian)]
  14. Lahousse L., Niemeijer M.N., van den Berg M.E., Rijnbeek P.R., Joos G.F., Hofman A., Franco O.H., Deckers J.W., Eijgelsheim M., Stricker B.H., Brusselle G.G. Chronic obstructive pulmonary disease and sudden cardiac death: the Rotterdam study. Eur. Heart. J. 2015;36(27):1754-61.
  15. Fuso L., Incalzi R., Pistelli R., Muzzolon R., Valente S., Pagliari G., Gliozzi F., Ciappi G. Predicting mortality of patients for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995;98(3):272-7.
  16. Козлова Л.И. Хронические обструктивные заболевания легких и ишемическая болезнь сердца. Некоторые аспекты функциональной диагностики. Пульмонология. 2001;2:9-12. [Kozlova L.I. Chronic obstructive pulmonary disease and coronary heart disease. Some aspects of functional diagnostics. Pulmonology. 2001;2:9-12 (in Russian)]
  17. Шойхет Я.Н., Клестер E.Б., Головин В.А. Нарушение ритма сердца у больных хронической обструктивной болезнью легких в сочетании с ишемической болезнью сердца. Клиническая медицина. 2008;3:21-5. [Shoykhet Y.N., Klester E.B., Golovin V.A. Heart rhythm disturbances in patients with chronic obstructive pulmonary disease combined with coronary heart disease. Clinical Medicine. 2008;3:21-5 (in Russian)]
  18. Акрамова Э.Г., Хамитова Р.Я. Сопутствующая кардиальная патология у больных хронической обструктивной болезнью легких: диагностика и экономика. Тер. арх. 2014;86(3):24-7. [Akramova E.G., Khamitova R.Y. Associated cardiac pathology in patients with chronic obstructive pulmonary disease: diagnosis and economy. Therapeutic Archives. 2014; 86 (3):24-7 (in Russian)]
  19. Khokhar N. Cardiac arrhythmias associated with acute respiratory failure in chronic obstructive pulmonary disease. Milit. Med. 1981;146:856-8.
  20. Shih H., Webb C., Conway W., Peterson E., Tilley B., Goldstein S. Frequency and significance of cardiac arrhythmias in chronic obstructive pulmonary disease. Chest. 1988;94:44-8.
  21. Theofilogiannakos E., Anogeianaki A., Tsekoura P., Glouftsios P., Ilonidis G., Hatzitolios A., Anogianakis G. Arrhythmogenesis in patients with stable chronic obstructive pulmonary disease. J. Cardiovasc. Med. (Hagerstown) 2008;1:89-93.
  22. Tukek T., Yildiz P., Akkaya V., Karan M.A., Atilgan D., Yilmaz V., Korkut F. Factors associated with the development of atrial fibrillation in COPD patients: the role of P-wave dispersion. Ann. Noninvasive Electrocardiol. 2002;3:222-7.
  23. Коррейа Л.Л., Лебедев Т.Ю., Ефремова О.А., Прощаев К.И., Литовченко Е.С. Проблема полиморбидности при сочетании хронической обструктивной болезни легких и некоторых сердечно-сосудистых заболеваний. Научные ведомости Белгородского государственного университета. Серия: Медицина. Фармация. 2013;21(4):12-7. [Korreya L.L., Lebedev T.Y., Efremova О.А., Proshchaev K.I., Litovchenko E.S. Polymorbidity problem in conjunction with chronic obstructive pulmonary disease and certain cardiovascular diseases. Scientific statements Belgorod State University. Series: Medicine. Pharmacy. 2013;21(4):12-7 (in Russian)]
  24. Леонова Е.И., Шехян Г.Г., Задионченко В.С., Багатырова К.М. Фибрилляция предсердий у больных хронической обструктивной болезнью легких. Рациональная фармакотерапия в кардиологии. 2014;3:328-33. [Leonova E.I., Shekhyan G.G., Zadinochenko V.S., Bagatyrova K.M. Atrial fibrillation in patients with chronic obstructive pulmonary disease. Rational Pharmacotherapy in Cardiology. 2014;3:328-33 (in Russian)]
  25. Yildiz P., Tukek T., Akkaya V., Sözen A.B., Yildiz A., Korkut F., Yilmaz V. Ventricular arrhythmias in patients with COPD are associated with QT dispersion. Chest. 2002;6:2055-61.
  26. Урясьев О.М., Варварин В.М. К вопросу о патогенезе нарушений сердечного ритма при заболеваниях легких. Российский медикобиологический вестник им. академика И.П. Павлова. 2008;2:140-6. [Uryas'ev О.М., Varvarin V.M. On the issue of pathogenesis of cardiac arrhythmias in diseases of the lungs. Russian biomedical herald named after academician I.P. Pavlov. 2008;2:140-6 (in Russian)]
  27. Salpeter S.R., Ormiston T.M., Salpeter E.E. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis. Chest. 2004;125(6):2309-21.
  28. Кароли Н.А., Ребров А.П. Некоторые аспекты кардиоваскулярной безопасности тиотропия у больных хронической обструктивной болезнью легких и ишемической болезнью сердца. Consilium Medicum. 2013;3:24-8. [Karolin N.A., Rebrov A.P. Some aspects of cardiovascular safety of tiotropium in patients with chronic obstructive pulmonary disease and coronary heart disease. Consilium Medicum. 2013;3:24-8 (in Russian)]
  29. Worth H., Chung K.F., Felser J.M., Hu H., Rueegg P. Cardio- and cerebrovascular safety of indacaterol vs formoterol, salmeterol, tiotropium and placebo in COPD. Respir.Med. 2011;105(4):571-9.
  30. Bittar G., Friedman H. The arrhythmogenicity of theophylline. A multivariate analysis of clinical determinants. Chest. 1991 99(6):1415-20.
  31. Reinier K., Uy-Evanado A., Teodorescu C., et al. Predictors of Sudden Cardiac Arrest with Preserved Left Ventricular Systolic Function. Circulation. 2010;122:A18593.
  32. Рекомендации 2006 года Американской коллегии кардиологов, Американской ассоциации сердца и Европейского общества кардиологов по лечению пациентов с желудочковыми аритмиями и профилактике внезапной сердечной смерти. Кардиология. 2011;51(7):65-96. [Recommendation from 2006 of American College of Cardiology, the American Heart Association and the European Society of Cardiology for the treatment of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Kardiologiia. 2011;51(7):65-96 (in Russian)]
  33. Барсуков А.В., Харитонов М.А., Глонти М.С., Каляев А.В. Лекарственно-индуцированное удлинение интервала QT электрокардиограммы при различных вариантах антибактериальной терапии. 2013; http://medznate.ru/docs/index-36944.html [Barsukov А.V., Kharitonov М.А., Glotin M.S., Kalyaev А.V. Drug-induced QT interval prolongation in the electrocardiogram of various embodiments of antibiotic therapy. 2013; http://medznate.ru/docs/index-36944.html (in Russian)]
  34. Incalzi R., Pistelli R., Fuso L., Cocchi A., Bonetti M.G., Giordano A. Cardiac arrhythmias and left ventricular function in respiratory failure from chronic COPD. Chest. 1990;97(5);1092-7.
  35. Новикова Т.Н. Новые рекомендации европейского общества кардиологов по лечению фибрилляции предсердий: время перемен. Проблемы женского здоровья. 2011;1:37-46. [Novikova T.N. The new recommendations of the European Society of Cardiology for the treatment of atrial fibrillation: a time of change. Problems of women's health. 2011;1:37-46 (in Russia)]

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2016

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies